13F-HR filed by Merck & Co., Inc.
Merck & Co., Inc. filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-13, with 14 holding rows worth $349,437,632.
- Accession
- 0000310158-26-000141
- Filer
- CIK 310158
- Filed
- 2026-05-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 14 entries on the cover page, a total value of $349,437,632 stated on the cover page (in dollars after the unit check, H1), rows summing to $349,437,632 with VALUE read as dollars as filed, 13F file number 028-25193. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerMERCK SHARP & DOHME LLC
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MODERNA INC | 60770K107 | COM | 2,308,190 | $117,256,052 | dollars as filed | |
| PERSONALIS INC | 71535D106 | COMMON STOCK | 14,044,943 | $89,466,287 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 772,165 | $64,313,623 | dollars as filed | |
| ENTRADA THERAPEUTICS INC | 29384C908 | COM | 1,739,768 | $21,955,872 | dollars as filed | |
| EIKON THERAPEUTICS INC | 282564103 | COMMON STOCK | 1,666,666 | $17,633,326 | dollars as filed | |
| AKTIS ONCOLOGY INC | 01021M104 | COMMON STOCK | 952,844 | $17,046,379 | dollars as filed | |
| ALECTOR INC | 014442107 | COMMON STOCK | 3,545,719 | $7,623,297 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 272,351 | $6,784,263 | dollars as filed | |
| EVAXION BIOTECH A/S | 29970R204 | SPONSORED ADS | 1,214,126 | $4,516,549 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 93,414 | $1,827,178 | dollars as filed | |
| XILIO THERAPEUTICS INC | 98422T209 | COM | 105,982 | $891,309 | dollars as filed | |
| CARISMA THERAPEUTICS INC | 14216R101 | COM | 1,473,240 | $47,880 | dollars as filed | |
| NEUPHORIA THERAPEUTICS INC | 64136E102 | COM | 10,027 | $40,810 | dollars as filed | |
| TUHURA BIOSCIENCES INC | 898920103 | COM | 19,445 | $34,807 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000310158-26-000141 | this filing | 2026-05-13 | acceptance time not in the bulk data set |